HemoCue Cognatus - Ett Intelligent Analysinstrument
HemoCue AB is a multinational corporation targeted on manufacturing point-of-care analysisinstruments for medical treatment. Their main product, the DM 201, is outdated and has bigissues gaining new market shares. For example, no medical treatment center in Sweden usesDM 201 frequently. The project of developing a new instrument to replace it was assignedtwo students at the development engineering program at Halmstad University. The projectalso included integration of the new platform for DM 202 to HemoCue AB:s remainingproducts.The project began by defining the different technical areas concerned. By identifying six bigtechnical areas and reaching a technical height within these areas the project group was ableto combine the new knowledge and assemble them to a satisfying result. The project groupdeveloped a new instrument with a 50 % decreased volume compared to the DM 201. Thecomponents are carefully selected to match the technical progress in the medical treatmentbusiness over the past years. The original project also resulted in a side project containing anew cuvette unit which is decreased by 75 % compared with today?s unit. This new cuvetteunit also performs more accurate analysis. When the goals where reached for DM 202, theproject group started to integrate useful components into the remaining product range. Tomake this possible the group had to redesign all the remaining instruments both internal andexternal.The superior work of the project group has resulted in a completely new product range forHemoCue AB. Consisting of intelligent, powerful instrument that will be very attractive onthe market.